Home
News
Latest News
People Moves
Business Briefs
Newsletters
Features
Features
Reprints
Surveys
Editorial Calendar
Web Exclusives
Issue Archive
Events
MM&M Awards 2012
txt4pharma
MM&M Virtual Summit
Webcasts
Leadership Exchanges
Whitepapers
Directories
Creative Portfolio
Mobile Guide
Interactive Guide
Pharmaceutical Marketers Directory
MM&M Service Directory
Agency Gallery
Direct Marketing Showcase
Medical Education Review
Sales Force Listings
Jobs
About Us
Subscriber Services
Contact Us
Media Information
Editorial Advisory Board
Drug Info
New Drug Dossier
Drug Database
Subscribe
Order Now
Subscriber Services
Newsletters
RSS
|
Login
|
Register
Media Forum Articles
Why is print's power still prevalent?
Kevin McCaffrey
May 01, 2012
Media data show pharma spent more for ads in magazines (+1%) and newspapers (+3%) last year, along with journals (+6%), but less in TV, outdoor and radio. What's behind the power of print as an ad vehicle?
Is ivory tower free of industry bias?
Kevin McCaffrey
April 01, 2012
Is academic research any more timely or transparent than industry research?
Do reviews have an evidence gap?
Marc Iskowitz
, Kevin McCaffrey March 01, 2012
Missing documents allegedly kept a review of Tamiflu from conclusively examining the drug's efficacy. Are reviews marred by publication and reporting biases? What can be done to make assessments more robust?
Will 2012 ad spend go for the gold?
February 01, 2012
For media buyers, 2012 means the "quadrennial" cyclical driver. The Summer Olympics and European Soccer Championship are expected to boost advertising. Will we see more spending in the healthcare sector?
Is consolidation the coming thing?
January 01, 2012
Several clients consolidated their advertising and promotion business last year, awarding all-in-one agency-of-record status for franchises, often including media duties. Should we expect more consolidations this year?
What's behind print's banner year?
December 01, 2011
Pharma DTC ad spend rose 4% through July 2011, vs. YTD July 2010, according to SDI, with magazine buys up 18%. Why is print up?
Will personalization cut ad spending?
November 01, 2011
What are the implications of personalized medicine for media? Do more targeted therapies mean a precipitous drop in ad spend, or will spending migrate to different channels?
Is focus on HCPs becoming a trend?
August 15, 2011
Wolters Kluwer Health is divesting its Pharma Solutions unit to focus on apps and journals. Does this move away from an audience of pharmas and medical agencies to focus on HCPs portend a trend or not?
What will Google+ mean for pharma?
July 15, 2011
Google tried one-upping its rival when it released a Facebook-esque package of social media features known as Google+. Is this a game changer, and what will it mean for pharma marketers?
Where will pharma's web dollars go?
May 13, 2011
This year the healthcare/pharma industry is expected to increase web media spend 13% to $1.2 billion, according to an eMarketer forecast. Where should that spending go?
« Previous
Next »
Video Exclusive
Web Exclusives
Five industry experts advise specialty pharma company on digital strategy
April 20, 2012
Specialty pharma company POZEN assembled a crack team of experts to help shape its digital strategy. Not only did POZEN share with us the text from their contributions, but you can watch exclusive video clips of their valuable perspectives right here.
MM&M Awards 2011 HIghlights
The Best MM&M Awards Ever!
MAHF Ceremony 2012
Photos from the Medical Advertising Hall of Fame Awards ceremony
Most Popular
Most Emailed
Most Recent
Humira on solid ground, analysts say, despite vote on Pfizer hopeful
Goodbye Plavix, hello competition
Sales forces shrank in 2011, but not everywhere
Wolters Kluwer deals health analytics unit to private equity firm
RX-to-OTC proposal gets mixed reviews
No-see docs are know-nothings when it comes to new drug info, study suggests
Pharmas are from Mars, Payers are from Venus
Study: Young Latinas are key decision makers, prefer English
How CDC's hep.-C testing advice benefits drugmakers now
Coach vs. cancer in BMS-backed awareness effort
Harvard urges faculty to ditch journals
Study: Young Latinas are key decision makers, prefer English
Pharma Report 2012: Get Back in Shape
Massachusetts gift ban under attack (again)
Pfizer, Crestor tops for global promotional spend in 2011
Novo Nordisk plans US hiring spree as Q1 sales jump 10%
Med Ed Report: Show Me the Money
No-see docs are know-nothings when it comes to new drug info, study suggests
Wolters Kluwer deals health analytics unit to private equity firm
Humira on solid ground, analysts say, despite vote on Pfizer hopeful
Did FDA's Vytorin warning negatively impact health outcomes?
Roundtable outlines path for publisher, pharma credibility
No-see docs are know-nothings when it comes to new drug info, study suggests
E-prescriptions boost adherence data
How CDC's hep.-C testing advice benefits drugmakers now
PhRMA's Washington wish list
Study: Young Latinas are key decision makers, prefer English
Pharmas are from Mars, Payers are from Venus
Goodbye Plavix, hello competition
Indian conglomerate buys Manhattan Research parent for $635m
Popular Topics
Acquisition
Adherence
App
Celebrity
Clinical Trial
Co-Marketing
Diabetes
Diagnostics
Digital
Direct To Consumer (DTC)
Disease Awareness
Downsize
Education & Awareness
FDA
Government
Guidance
Health Plans
HMOs
Hospitals
Insurers
Law
Marketing Research
Medical Journal
Mobile
Sales Force